FrancophonIA/ELRC3.0 huggingface dataset:
English: As for all medicines, data on the use of Lumark are continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Lumark stalno spremljajo.
English: Information on how to minimise the risks is included in the product information for Lumark.
Slovenian: Informacije o tem, kako zmanjšati tveganja, so vključene v informacije o zdravilu Lumark.
English: The radiolabelled medicine is then given to the patient according to the instructions in that medicine's product information.
Slovenian: Nato bolnik prejme radiooznačeno zdravilo v skladu z navodili iz informacij o označenem zdravilu.
English: Radiolabelling is a technique for tagging (or labelling) medicines with radioactive compounds so they can carry radioactivity to where it is needed in the body, for example, the site of a tumour.
Slovenian: Radiooznačevanje je tehnika za označevanje zdravil z radioaktivnimi spojinami, tako da lahko prenesejo radioaktivnost v tiste dele telesa, kjer je potrebna, na primer na mesto tumorja.
English: Medicines radiolabelled with Lumark must not be used in women unless pregnancy has been ruled out.
Slovenian: Zdravila, radiooznačena z zdravilom Lumark, se ne smejo uporabljati pri nosečnicah ali ženskah, ki bi lahko bile noseče.
English: What are the risks associated with Lumark?
Slovenian: Kakšna tveganja so povezana z zdravilom Lumark?
English: The active substance in Lumark, lutetium (177Lu) chloride, is a radioactive compound that mainly releases beta radiation, with small amounts of gamma radiation.
Slovenian: Učinkovina v zdravilu Lumark, lutecijev (177Lu) klorid, je radioaktivna spojina, ki v glavnem oddaja sevanje beta, skupaj z majhnimi količinami sevanja gama.
English: Because the use of lutetium (177Lu) to radiolabel medicines is well established, the company presented data from the scientific literature.
Slovenian: Ker je uporaba lutecija (177Lu) za radiooznačevanje zdravil dobro uveljavljena, je podjetje predložilo podatke iz znanstvene literature.
English: Lumark itself is radioactive, and as with any other radioactive product, its use may carry a risk of developing cancer and hereditary defects.
Slovenian: Zdravilo Lumark je radioaktivno, zato pri njegovi uporabi enako kot pri uporabi katerega koli drugega radioaktivnega proizvoda obstaja tveganje za nastanek raka in dednih okvar.
English: Information on restrictions that apply specifically to medicines radiolabelled with Lumark can be found in the package leaflets of those medicines.
Slovenian: Informacije o omejitvah, ki veljajo posebej za zdravila, radiooznačena z zdravilom Lumark, bodo na voljo v navodilih za uporabo teh zdravil.
English: The European Medicines Agency considered that the use of lutetium (177Lu) for radiolabelling medicines was well established and well documented in the scientific literature.
Slovenian: Evropska agencija za zdravila je menila, da je uporaba lutecija (177Lu) za radiooznačevanje zdravil dobro uveljavljena in dobro dokumentirana v znanstveni literaturi.
English: For the list of all side effects and restrictions with Lumark, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila Lumark glejte navodilo za uporabo.
English: Lumark contains the radioactive compound lutetium (177Lu) chloride and is used for radiolabelling other medicines.
Slovenian: Zdravilo Lumark vsebuje radioaktivno spojino lutecijev (177Lu) klorid in se uporablja za radiooznačevanje drugih zdravil.
English: Several published studies have established the usefulness of lutetium (177Lu) in radiolabelling medicines for diagnosing and treating neuroendocrine tumours.
Slovenian: V več objavljenih študijah so potrdili uporabnost lutecija (177Lu) pri radiooznačevanju zdravil za diagnostične namene in zdravljenje nevroendokrinih tumorjev.
English: The side effects with Lumark depend largely on the medicine it is used with and are described in that medicine's package leaflet.
Slovenian: Neželeni učinki pri uporabi zdravila Lumark so odvisni predvsem od zdravila, s katerim se uporablja, in so opisani v navodilu za uporabo tega zdravila.
English: As with all radiolabelling materials for medicines, there are risks linked to radiation exposure from Lumark.
Slovenian: Tako kot pri uporabi drugih snovi za radiooznačevanje zdravil tudi pri uporabi zdravila Lumark obstajajo tveganja, povezana z izpostavljenostjo njegovemu sevanju.
English: Lumark is to be used to radiolabel medicines that have been specifically developed for use with lutetium (177Lu) chloride.
Slovenian: Zdravilo Lumark je namenjeno radioaktivnemu označevanju tistih zdravil, ki so bila razvita posebej za uporabo z lutecijevim (177Lu) kloridom.
English: How does Lumark work?
Slovenian: Kako zdravilo Lumark deluje?
English: How is Lumark used?
Slovenian: Kako se zdravilo Lumark uporablja?
English: How well Lumark works will largely depend on the medicine that it is used to radiolabel.
Slovenian: Učinkovitost delovanja zdravila Lumark je predvsem odvisna od zdravila, za radiooznačevanje katerega se uporabi.
English: Lu) chloride)
Slovenian: Lumark (lutecijev [177Lu] klorid)
English: The vaccine was generally well tolerated and shown to be safe.
Slovenian: Živali so cepivo na splošno dobro prenašale in izkazalo se je kot varno.
English: They may also have a swelling at the injection site lasting no more than seven days or a hardening under the skin (nodules), which could last more than six or seven weeks.
Slovenian: Lahko se pojavi tudi oteklina na mestu injiciranja, ki ne traja več kot sedem dni, ali zatrdline pod kožo, ki lahko trajajo več kot šest ali sedem tednov.
English: Following vaccination sheep may have a slightly raised body temperature.
Slovenian: Po cepljenju se lahko pri ovcah pojavi rahlo povišana telesna temperatura.
English: The studies showed that the vaccine prevents viraemia in sheep and offered protection for one year.
Slovenian: Študije so pokazale, da cepivo preprečuje viremijo pri ovcah in da traja zaščita eno leto.
English: The safety of the vaccine was studied in two main laboratory safety studies carried out in sheep and two studies carried out in pregnant ewes.
Slovenian: Varnost zdravila je bila raziskana v dveh glavnih laboratorijskih študijah varnosti, ki sta bili opravljeni pri ovcah, in dveh študijah, opravljenih pri brejih ovcah.
English: Protection starts three weeks after the last injection and lasts for a year.
Slovenian: Zaščita je učinkovita od tretjega tedna po zadnji injekciji in traja eno leto.
English: The effectiveness of the vaccine was studied in three main laboratory studies in lambs from 1 months of age.
Slovenian: Učinkovitost cepiva je bila proučena v treh glavnih laboratorijskih študijah pri jagnjetih, starejših od enega meseca.
English: In 2012 the CVMP considered that the submitted data were adequate for the authorisation of Zulvac 1 Ovis to convert to normal.
Slovenian: Leta 2012 je CVMP menil, da predloženi podatki zadostujejo, da se dovoljenje za promet z zdravilom Zulvac 1 Ovis spremeni v običajno.
English: Zulvac 1 Ovis was initially authorised under ‘exceptional circumstances'.
Slovenian: Zdravilo Zulvac 1 Ovis je prvotno pridobilo dovoljenje za promet v „izjemnih okoliščinah“.
English: The vaccine is safe for sheep from one and a half months of age onwards and in pregnant ewes.
Slovenian: Cepivo je varno za uporabo pri ovcah, starejših od enega meseca in pol ter pri brejih ovcah.
English: When it is given to sheep, the immune system recognises the viruses as ‘foreign' and makes antibodies against them.
Slovenian: Ko ovca prejme cepivo, imunski sistem virus prepozna kot „tujek“ in proti njemu razvije protitelesa.
English: In the future, if the animals are exposed to the bluetongue virus, the immune system will be able to produce antibodies more quickly.
Slovenian: Ob ponovni izpostavitvi virusu bolezni modrega jezika v prihodnosti bo imunski sistem tako hitreje tvoril protitelesa.
English: The studies goal was to establish the smallest dose of vaccine that prevented viraemia as well as the duration of protection for Zulvac 1 Ovis.
Slovenian: Cilja študij sta bila določiti najmanjši odmerek, ki preprečuje viremijo, in ugotoviti trajanje zaščite po cepljenju s cepivom Zulvac 1 Ovis.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Zulvac 1 Ovis on 05/08/2011.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Zulvac 1 Ovis, veljavno po vsej Evropski uniji, odobrila dne 5. avgusta 2011.
English: Zulvac 1 Ovis is a vaccine that is available as a suspension for injection.
Slovenian: Zdravilo Zulvac 1 Ovis je cepivo, ki je na voljo v obliki suspenzije za injiciranje.
English: The animals were challenged with bluetongue virus serotype 1, after receiving Zulvac 1 Bovis vaccine containing different amounts of virus.
Slovenian: Živali so izpostavili serotipu 1 virusa bolezni modrega jezika po tem, ko so bile cepljene s cepivom Zulvac 1 Ovis, ki je vsebovalo različne količine virusa.
English: Other information about Zulvac 1 Ovis:
Slovenian: Druge informacije o zdravilu Zulvac 1 Ovis:
English: Zulvac 1 Ovis is a vaccine.
Slovenian: Zdravilo Zulvac 1 Ovis je cepivo.
English: What benefit has Zulvac 1 Ovis shown during the studies?
Slovenian: Kakšne koristi je zdravilo Zulvac 1 Ovis izkazalo med študijami?
English: The withdrawal period for Zulvac 1 Ovis for meat and milk is zero days.
Slovenian: Karenca za cepivo Zulvac 1 Ovis za meso in mleko je nič dni.
English: Zulvac 1 Bovis contains bluetongue virus of one serotype (serotype 1).
Slovenian: Cepivo Zulvac 1 Ovis vsebuje virus bolezni modrega jezika enega tipa (serotip 1).
English: Zulvac 1 Ovis is used in sheep to protect them against bluetongue disease, an infection caused by the bluetongue virus which is transmitted by midges.
Slovenian: Zdravilo Zulvac 1 Ovis se uporablja pri ovcah za zaščito pred boleznijo modrega jezika, tj. okužbo, ki jo povzroča virus modrega jezika, prenašajo pa jo trzače.
English: This means that it was not possible to obtain complete information about Zulvac 1 Ovis at the time of the initial authorisation.
Slovenian: To pomeni, da ob prvotni izdaji dovoljenja za promet ni bilo mogoče pridobiti vseh podatkov o cepivu Zulvac 1
English: What is the risk associated with Zulvac 1 Ovis?
Slovenian: Kakšna tveganja so povezana z zdravilom Zulvac 1 Ovis?
English: The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Zulvac 1 Ovis exceed the risks in the prevention of viraemia caused by Bluetongue Virus, serotype 1 in sheep from one and a half months of age.
Slovenian: CVMP je zaključil, da so pri ovcah, starejših od enega meseca in pol, koristi cepiva Zulvac 1 Ovis pri preprečevanju viremije, ki jo povzroča serotip 1 virusa bolezni modrega jezika, večje od z njim povezanih tveganj.
English: Why has Zulvac 1 Ovis been approved?
Slovenian: Zakaj je bilo zdravilo Zulvac 1 Ovis odobreno?
English: Zulvac 1 Ovis contains bluetongue viruses that have been inactivated so that they cannot cause the disease.
Slovenian: Cepivo Zulvac 1 Ovis vsebuje inaktiviran virus bolezni modrega jezika, ki ne povzroča bolezni.
English: The vaccine is used to prevent viraemia (the presence of the viruses in the blood) in sheep from one and a half months of age.
Slovenian: Cepivo se uporablja za preprečevanje viremije (prisotnosti virusov v krvi) pri ovcah, starejših od enega meseca in pol. Cepivo se mladičem injicira pod kožo v dveh odmerkih.
English: Inactivated vaccine against Bluetongue disease virus, serotype 1
Slovenian: Zulvac 1 Ovis inaktivirano cepivo proti virusu modrega jezika, serotip 1
English: What is Zulvac 1 Ovis?
Slovenian: Kaj je zdravilo Zulvac 1 Ovis?
English: How has Zulvac 1 Ovis been studied?
Slovenian: Kako je bilo zdravilo Zulvac 1 Ovis raziskano?
English: What is ZULVAC 1 Ovis used for?
Slovenian: Za kaj se zdravilo Zulvac 1 Ovis uporablja?
English: How does Zulvac 1 Ovis work?
Slovenian: Kako zdravilo Zulvac 1 Ovis deluje?
English: Animals should be re-examined every 6 months during treatment.
Slovenian: Živali je treba med zdravljenjem vsakih 6 mesecev pregledati.
English: Dogs (bitches).
Slovenian: Psi (psice)
English: See also 4.3 Contraindications.
Slovenian: Glejte tudi 4.3 Kontraindikacije.
English: The incidence is about 59 %.
Slovenian: Pogostnost teh pojavov je približno 5 do 9 %.
English: Pharmacotherapeutic group: estrogens, ATCvet code: QG03CA04.
Slovenian: Farmakoterapevtska skupina: estrogeni, oznaka ATCvet: QG03CA04.
English: SPECIAL WARNINGS, IF NECESSARY Not applicable.
Slovenian: POSEBNA OPOZORILA, ČE SO POTREBNA Ni smiselno.
English: 11 PROHIBITION OF SALE, SUPPLY AND/OR USE Not applicable.
Slovenian: PREPOVED PRODAJE, OSKRBE IN/ALI UPORABE Ni smiselno.
English: Nearly the whole Estriol is bound to Albumin in Plasma.
Slovenian: Skoraj ves estriol se veže na albumin v plazmi.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/00/018/001
Slovenian: ŠTEVILKA(E) DOVOLJENJ(A) ZA PROMET EU/2/00/018/001
English: Date of last renewal: March 2010
Slovenian: Datum podaljšanja: marec 2010
English: If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.
Slovenian: Če opazite kakršne koli resne neželene učinke ali druge učinke, ki niso omenjeni v teh navodilih za uporabo, obvestite svojega veterinarja.
English: B.V. Kloosterstraat 6 5349 AB Oss The Netherlands
Slovenian: Kloosterstraat 6 5349 AB Oss Nizozemska
English: The minimum dose given should not be less than 0.5 mg per dog per day.
Slovenian: Najmanjši odmerek ne sme biti manjši od 0,5 mg na dan na psico.
English: 9 DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION Date of first authorisation: March 2000
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum prve odobritve: marec 2000
English: In the target animal safety study and the clinical trials, including long-term treatment, no signs of bone marrow suppression were observed.
Slovenian: V študijah varnosti pri ciljni živalski vrsti in kliničnih preskušanjih, tudi pri dolgotrajnem zdravljenju, niso zasledili znakov supresije kostnega mozga.
English: The dose has to be fixed for each dog on an individual basis.
Slovenian: Odmerek je treba psicam določiti individualno.
English: If no response to treatment is obtained the diagnosis should be reconsidered in order to investigate other causes for the incontinence such as neurological disorders, bladder neoplasia, etc.
Slovenian: Če na zdravljenje ni odziva, moramo ponovno presoditi o diagnozi, da bi odkrili morebitne druge vzroke inkontinence, kot so nevrološke motnje, neoplazija mehurja in druge.
English: Amylopectin Potato starch Magnesium stearate Lactose
Slovenian: Amilopektin Krompirjev škrob Magnezijev stearat Laktoza
English: Do not use after the expiry date which is stated on the label after Exp.
Slovenian: Zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na ovojnini po Exp.
English: Incurin is intended for once daily oral administration.
Slovenian: Incurin dajemo enkrat na dan peroralno.
English: Aspen Oss.
Slovenian: Aspen Oss B.V.
English: The use of Incurin is contraindicated during pregnancy, lactation and in animals younger than 1 year.
Slovenian: Uporaba Incurina je kontraindicirana v obdobju brejosti, laktacije in pri živalih, mlajših od 1 leta.
English: NAME OF THE MARKETING AUTHORISATION HOLDER Intervet International B.V.
Slovenian: IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Intervet International B.V.
English: For oral administration.
Slovenian: Za peroralno dajanje.
English: Animals showing a polyuria-polydipsia should not be treated with Incurin.
Slovenian: Živali s sindromom poliurije-polidipsije ne smemo zdraviti z Incurinom.
English: Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
Slovenian: Vsako neporabljeno zdravilo ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi predpisi.
English: Further, in some dogs, symptoms of nausea were observed.
Slovenian: Pri nekaterih psicah so se pojavili simptomi slabosti.
English: In rare cases development of alopecia has also been observed.
Slovenian: Zasledili so še redke primere razvoja alopecije.
English: PHARMACEUTICAL FORM Tablet.
Slovenian: FARMACEVTSKA OBLIKA Tableta
English: Ensure the dose used to achieve the therapeutic effect is as low as possible.
Slovenian: Terapevtski učinek je treba doseči s čim manjšim odmerkom.
English: Estriol is excreted in conjugated from via the urine.
Slovenian: Estriol se izloča v konjugirani obliki z urinom.
English: A relationship between final effective dose and body weight has not been established and therefore the dose has to be determined for each dog on an individual basis.
Slovenian: Razmerje med končnim učinkovitim odmerkom in telesno maso ni določeno, zato moramo ustrezen odmerek določiti individualno.
English: Since there exists no relation between the final effective dose and the body weight, a fixed dose per kg body weight is not feasible.
Slovenian: Ker med končnim učinkovitim odmerkom in telesno maso ni povezave, fiksnega odmerka na kilogram telesne mase ne moremo določiti.
English: High doses of oestrogen may have a tumour-promoting effect in target organs with oestrogen receptors (mammary glands).
Slovenian: Veliki odmerki estrogena lahko spodbudijo rast tumorja na ciljnih organih z estrogenskimi receptorji (mlečna žleza).
English: One blister contains 30 tablets.
Slovenian: En pretisni omot vsebuje 30 tablet.
English: Dog.
Slovenian: Pes
English: Estriol is a short-acting natural oestrogen.
Slovenian: Estriol je kratkodelujoči naravni estrogen.
English: ADVICE ON CORRECT ADMINISTRATION Not applicable.
Slovenian: NASVET O PRAVILNI UPORABI ZDRAVILA Navedba ni smiselna.
English: This is probably due to the short-acting oestrogenic character of estriol.
Slovenian: To je verjetno posledica kratkotrajnega estrogenega učinka estriola.
English: Name and address of the manufacturer(s) of the biological active substance(s)
Slovenian: Ime in naslov izdelovalca(izdelovalcev) biološke zdravilne učinkovine (zdravilnih učinkovin).
English: The following dosing schedule is advised: start treatment with 1 tablet (1 mg estriol) every day.
Slovenian: Priporočena shema odmerjanja: zdravljenje začnemo z 1 tableto (1 mg estriola) na dan.
English: MANUFACTURER'S BATCH NUMBER Batch number.
Slovenian: IZDELOVALČEVA ŠTEVILKA SERIJE Številka serije
English: The following dosing schedule is advised: start treatment with 1 tablet every day.
Slovenian: Priporočena shema odmerjanja: zdravljenje začnemo z 1 tableto na dan.
English: 6.5 Nature and composition of immediate packaging Blister package of clear PVC film backed by aluminium foil provided with heat seal coating (vinyl copolymer) on the side in contact with the tablets.
Slovenian: Pretisni omot iz prozornega filma iz pvc in aluminijaste folije s toplotno zavarjeno oblogo (kopolimer vinila) na strani, ki je v stiku s tabletami.
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
Slovenian: IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM TER IMETNIKA DOVOLJENJA ZA IZDELAVO ZDRAVILA, ODGOVORNEGA ZA SPROSTITEV SERIJ, ČE STA RAZLIČNA
English: Do not use more than 2 tablets per dog per day.
Slovenian: Dnevni odmerek naj ne prekorači 2 tablet na dan na psico.
English: THE WORDS “FOR ANIMAL TREATMENT ONLY” For animal treatment only - to be supplied only on veterinary prescription.
Slovenian: BESEDILO “SAMO ZA ŽIVALI” Samo za živali - na veterinarski recept.
English: Each strip is packed in a carton box.
Slovenian: Po en trak je pakiran v zloženki.
English: In rare cases vaginal bleeding occurred.
Slovenian: Redko se je pojavila krvavitev iz nožnice.
English: PACKAGE SIZE Carton box with 1 blister.
Slovenian: VELIKOST PAKIRANJA Zloženka z 1 pretisnim omotom.
English: Some dogs do not need daily treatment; treatment every other day may be tried once the effective daily dose has been established.
Slovenian: Nekatere psice zdravila ne potrebujejo vsak dan; ko določimo učinkovit dnevni odmerek, lahko zdravilo poskusimo dajati vsak drugi dan.
English: These effects are reversible after lowering the dose.
Slovenian: Ti učinki minejo, če odmerek zmanjšamo.
English: STATEMENT OF ACTIVE AND OTHER SUBTANCES Active substance: estriol 1 mg/tablet
Slovenian: NAVEDBA ZDRAVILNE UČINKOVINE IN DRUGIH SNOVI Zdravilna učinkovina: estriol, 1 mg v 1 tableti
English: EXPIRY DATE (Month / year)
Slovenian: DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA (Mesec/leto)
English: In ovarioectomised female dogs it has a beneficial effect on urinary incontinence.
Slovenian: Pri psicah po ovariohisterektomiji ima ugoden učinek na urinsko inkontinenco.
English: After oral administration of multiple doses no accumulation occurs.
Slovenian: Po večkratnem peroralnem dajanju ne prihaja do kopičenja.
English: In the incontinent female dog it has a beneficial effect on the urinary incontinence.
Slovenian: Pri psicah z inkontinenco ima ugoden učinek na urinsko inkontinenco.
English: EXPIRY DATE Exp (Month / year)
Slovenian: DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA Exp {mesec/leto}
English: Do not use in intact bitches, as the efficacy has only been established in ovariohysterectomised bitches.
Slovenian: Zdravila ne smemo uporabljati pri psicah, pri katerih ovariohisterektomija ni bila opravljena, ker je učinkovitost zdravila dokazana samo pri psicah po ovariohisterektomiji.
English: 4.7 Use during pregnancy, lactation or lay
Slovenian: 4.7 Uporaba v obdobju brejosti, laktacije ali nesnosti Zdravila ne uporabite v obdobju brejosti ali laktacije.
English: 4.2 Indications for use, specifying the target species The treatment of hormone-dependent urinary incontinence due to sphincter mechanism incompetence in ovariohysterectomised bitches.
Slovenian: 4.2 Indikacije za uporabo pri ciljnih živalskih vrstah Zdravljenje hormonsko odvisne urinske inkontinence, ki je posledica nepravilnega delovanja sfinkterskega mehanizma pri psicah po ovariohisterektomiji.
English: Name and address of the manufacturer(s) responsible for batch release
Slovenian: Ime in naslov izdelovalca(izdelovalcev) zdravila, odgovornega za sproščanje serije
English: In case of overdose typical oestrogen effects may occur.
Slovenian: Preveliki odmerki lahko imajo značilne estrogene učinke.
English: 4.9 Amount(s) to be administered and administration route
Slovenian: 4.9 Odmerjanje in pot uporabe
English: After oral administration Estriol is nearly completely absorbed from gastrointestinal tract.
Slovenian: Estriol se po peroralnem dajanju iz prebavil skoraj povsem absorbira.
English: 1 mg/tablet For a full list of excipients, see section 6.1
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Zdravilna učinkovina: estriol, 1 mg v eni tableti Za celoten seznam pomožnih snovi glejte poglavje 6.1.
English: Incurin is indicated for the treatment of hormone-dependent urinary incontinence due to sphincter mechanism incompetence in female dogs.
Slovenian: Incurin je indiciran za zdravljenje hormonsko odvisne urinske inkontinence, ki je posledica nepravilnega delovanja sfinkterskega mehanizma pri psicah.
English: If treatment is not successful, increase the dose to 2 tablets a day to be given in one dose.
Slovenian: Če zdravljenje ni uspešno, odmerek povečamo na 2 tableti na dan, ki ju dajemo hkrati.
English: A. MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE
Slovenian: A. IZDELOVALEC(IZDELOVALCI) BIOLOŠKE ZDRAVILNE UČINKOVINE (ZDRAVILNIH UČINKOVIN) IN IMETNIK(I) DOVOLJENJ(A) ZA IZDELAVO ZDRAVILA, ODGOVOREN(ODGOVORNI) ZA SPROŠČANJE SERIJE
English: PACKAGE LEAFLET INCURIN 1 mg tablet
Slovenian: NAVODILO ZA UPORABO INCURIN 1 mg, tableta
English: 6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Slovenian: 6.6 Posebni varnostni ukrepi za odstranjevanje neporabljenega zdravila ali odpadnih snovi Vsako neporabljeno zdravilo ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi predpisi.